A study led by the ITACA Institute of the Universitat Politècnica de València, with the participation of the Institut Català d’Oncologia (ICO), the Institut Investigació Germans Trias I Pujol (IGTP) and the Hospital Clinic de Barcelona, opens up a novel approach for improving personalized treatments for patients with glioblastoma, one of the most aggressive types of cancer in existence today.
Study paves the way for improving personalized treatment of patients with glioblastoma
- Post author:
- Post published:January 31, 2024
- Post category:uncategorized